Zynex Faces Class Action Over Fraudulent Billing
Analysis based on 8 articles · First reported Feb 25, 2026 · Last updated Mar 02, 2026
A class action lawsuit has been filed against Zynex, a medical device manufacturer, on behalf of investors who purchased its securities between February 25, 2021, and December 15, 2025. The lawsuit, initiated by Robbins LLP, alleges that Zynex inflated its revenue by shipping products in excess of need and filing false claims, drawing scrutiny from insurers like United States===Tricare. The Travelers Companies has also sued Zynex and its executives, including Thomas Sandgaard, seeking over $23 million for a fraudulent overbilling scheme. Zynex reported a significant revenue shortfall and had payments temporarily suspended by United States===Tricare, its largest customer. These events led to substantial declines in Zynex's stock price. The company also underwent leadership changes, with Steven Dyson appointed as the new CEO and Daniel Moorhead departing as CFO.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard